These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19628262)

  • 21. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
    Sengupta S; Lohse CM; Leibovich BC; Frank I; Thompson RH; Webster WS; Zincke H; Blute ML; Cheville JC; Kwon ED
    Cancer; 2005 Aug; 104(3):511-20. PubMed ID: 15973740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
    Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
    Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How radical nephrectomy compares to partial nephrectomy for the treatment of pT1a papillary renal cell carcinomas?].
    Bigot P; Bernhard JC; Crepel M; Bensalah K; Azzouzi AR; de la Taille A; Salomon L; Tostain J; Ficarra V; Pantuck AJ; Belldegrun AS; Méjean A; Ferrière JM; Pfister C; Albouy B; Colombel M; Zini L; Villers A; Montorsi F; Shariat S; Rioux-Leclercq N; Patard JJ
    Prog Urol; 2010 May; 20(5):350-5. PubMed ID: 20471579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nephron-sparing surgery for localized kidney neoplasms--a report of 25 cases].
    Li YH; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Yu SL; Wang H
    Ai Zheng; 2006 Jan; 25(1):76-9. PubMed ID: 16405755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unclassified renal cell carcinoma: an analysis of 85 cases.
    Karakiewicz PI; Hutterer GC; Trinh QD; Pantuck AJ; Klatte T; Lam JS; Guille F; de La Taille A; Novara G; Tostain J; Cindolo L; Ficarra V; Schips L; Zigeuner R; Mulders PF; Chautard D; Lechevallier E; Valeri A; Descotes JL; Lang H; Soulie M; Ferriere JM; Pfister C; Mejean A; Belldegrun AS; Patard JJ
    BJU Int; 2007 Oct; 100(4):802-8. PubMed ID: 17822461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience.
    Pahernik S; Roos F; Hampel C; Gillitzer R; Melchior SW; Thüroff JW
    J Urol; 2006 Jun; 175(6):2027-31. PubMed ID: 16697793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Nephron-sparing surgery for 69 patients with renal tumors].
    Qiao MZ; Li CL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):335-8. PubMed ID: 16900628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm.
    Roos FC; Brenner W; Jäger W; Albert C; Müller M; Thüroff JW; Hampel C
    BJU Int; 2011 Feb; 107(4):554-61. PubMed ID: 20707798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
    Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
    BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
    Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
    J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of elective versus imperative indications on oncologic outcomes after open nephron-sparing surgery for the treatment of sporadic renal cell carcinomas.
    Coffin G; Hupertan V; Taksin L; Vaessen C; Chartier-Kastler E; Bitker MO; Rouprêt M
    Ann Surg Oncol; 2011 Apr; 18(4):1151-7. PubMed ID: 21136181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
    Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
    Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.
    Pflanz S; Brookman-Amissah S; Roigas J; Kendel F; Hoschke B; May M
    Scand J Urol Nephrol; 2008; 42(6):507-13. PubMed ID: 19031267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
    Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
    Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision.
    Ficarra V; Martignoni G; Galfano A; Novara G; Gobbo S; Brunelli M; Pea M; Zattoni F; Artibani W
    Eur Urol; 2006 Oct; 50(4):786-93; discussion 793-4. PubMed ID: 16697521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma.
    Eroğlu M; Unsal A; Bakirtaş H; Tekdoğan U; Ataoğlu O; Balbay MD
    Scand J Urol Nephrol; 2005; 39(3):222-5. PubMed ID: 16118094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of mini-margin nephron-sparing surgery for renal cell carcinoma 4-cm or less.
    Li QL; Cheng L; Guan HW; Zhang Y; Wang FP; Song XS
    Urology; 2008 May; 71(5):924-7. PubMed ID: 18267335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.